Calviri’s mission is to provide affordable products worldwide that will end deaths from cancer.  They are a fully integrated healthcare company developing a broad spectrum of vaccines and companion diagnostics that prevent and treat cancer for those either at risk or diagnosed.  They focus on using frameshift neoantigens derived from errors in RNA processing to provide pioneering products against cancer. 

Biotechnology

Calviri

Nikolina Nikolic

Alexandra Kassis

Terrence O’Neil

Kathryn Sykes

The Scientific and Research Team at Calviri is responsible for advancing the company's mission by conducting cutting-edge research on frameshift neoantigens and their applications in cancer prevention and treatment. This team of experts collaborates to develop innovative vaccines and diagnostics, leveraging their deep scientific expertise to drive discoveries from the lab to clinical applications.

Scientific and Research Team

About

Team members

Other teams at Calviri

Director Team

Leadership Team